Skip to main content
FinSpry Logo
FinSpry
OVID logo
OVID
(NASDAQ)
Ovid Therapeutics Inc.
$2.80-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Ovid Therapeutics (OVID) Stock Price & Financial Analysis

Ovid Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$2.71 - $2.83
52-Week High$3.11
52-Week Low$1.12
Open$2.74
Volume1.06M
Average Volume (3M)1.45M
Market Cap206.46M
Shares Outstanding73.74M
Price to Sales (P/S)28.99
Price to Book (P/B)1.04
EV/EBITDA-2.44
Revenue (TTM)7.12M
Net Income (TTM)-24.17M
Free Cash Flow (TTM)-41.95M
EPS (TTM)$-0.32
Profit Margin-339.33%
Operating Margin-670.25%
Return on Equity (ROE)-12.19%
Debt to Equity0.01
50-Day MA$2.61
200-Day MA$2.20
52-Week Change127.64%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Ovid Therapeutics

What is the current stock price for OVID?

As of the latest trading session, OVID stock trades at $2.80. The 52-week range is $1.12–$3.11, with a day range of $2.71–$2.83.

What is the P/E ratio for OVID?

The P/E ratio (Price-to-Earnings) for OVID is shown in the Key Statistics section. This valuation metric helps compare Ovid Therapeutics Inc. to industry peers.

Does OVID pay dividends?

Ovid Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for OVID?

Analyst ratings and recommendations for OVID are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.

What is the market cap of OVID?

Ovid Therapeutics's market capitalization is $206.5M, classifying it as a micro-cap company. Ovid Therapeutics operates in the Healthcare sector within the Biotechnology industry.